Etomidate

CAS 33125-97-2 7 current records 2 historicalSmall Molecule

Who holds supplier records for Etomidate? 7 organisations hold a current record for Etomidate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), United States (2), Switzerland (1), France (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Etomidate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/etomidate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Etomidate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Etomidate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Etomidate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
PISGAH LABORATORIES INC. Pisgah ForestUS
CEP 2020-231 - Rev 02
Etomidate
Aug 2025—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2017-278 - Rev 02
Etomidate
Sept 2024—
BACHEM S.A. VionnazCH
CEP 2005-250 - Rev 03
Etomidate
Mar 2024Inspected Oct 2025
Switzerland
HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. Linghu TownCN
R1-CEP 2016-298 - Rev 00
Etomidate
Apr 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Etomidate are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Overview

Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation for short procedures. It is known for its stable hemodynamic profile and minimal effect on cardiovascular function.

Chemical identity

IUPAC name
ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate
Canonical SMILES
CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2
InChIKey
NPUKDXXFDDZOKR-LLVKDONJSA-N
Synonyms
Amidate API, amidate, hypnomidate, nsc-759160

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
General Anesthetic
Physiologic effect
General Anesthesia

Therapeutic areas

AnesthesiologyCritical Care

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Etomidate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Etomidate: Bachem SA, Succursale de Vionnaz (Switzerland), SOLARA ACTIVE PHARMA SCIENCES LTD (India), CHEMWERTH INC (France), GLAND PHARMA LTD (India), PISGAH LABS INC (United States), Huzhou Zhanwang Pharmaceutical Co.,ltd. (China) and Pisgah Laboratories Inc (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Etomidate Drug Master Files are active?

Bachem SA, Succursale de Vionnaz (DMF 20234), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 27580), CHEMWERTH INC (DMF 20500), GLAND PHARMA LTD (DMF 34205) and PISGAH LABS INC (DMF 15983). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Etomidate records mean?

2 organisations have only inactive Type II DMFs for Etomidate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Etomidate have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Etomidate on the EDQM register, including PISGAH LABORATORIES INC. Pisgah Forest (US), SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN), BACHEM S.A. Vionnaz (CH) and HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. Linghu Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Etomidate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Etomidate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.